1.755 USD
-0.08 (-4.1%)
2.09 USD
+0.34 (+19.09%)
BLNE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 98 industry peers in the Financial Services industry. BLNE may be in some trouble as it scores bad on both profitability and health. BLNE is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year BLNE has reported negative net income.
BLNE had a negative operating cash flow in the past year.
In the past 5 years BLNE always reported negative net income.
BLNE had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of BLNE (-45.78%) is worse than 89.80% of its industry peers.
Looking at the Return On Equity, with a value of -55.90%, BLNE is doing worse than 86.73% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -45.78% | ||
| ROE | -55.9% | ||
| ROIC | N/A |
ROA(3y)-45.89%
ROA(5y)-36.44%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BLNE's Gross Margin of 22.00% is in line compared to the rest of the industry. BLNE outperforms 40.82% of its industry peers.
In the last couple of years the Gross Margin of BLNE has grown nicely.
The Profit Margin and Operating Margin are not available for BLNE so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.05%
GM growth 5Y5.13%
2. Health
2.1 Basic Checks
BLNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BLNE has been increased compared to 1 year ago.
BLNE has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, BLNE has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -0.61, we must say that BLNE is in the distress zone and has some risk of bankruptcy.
BLNE's Altman-Z score of -0.61 is on the low side compared to the rest of the industry. BLNE is outperformed by 67.35% of its industry peers.
A Debt/Equity ratio of 0.16 indicates that BLNE is not too dependend on debt financing.
BLNE's Debt to Equity ratio of 0.16 is fine compared to the rest of the industry. BLNE outperforms 69.39% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.61 |
ROIC/WACCN/A
WACC7.43%
2.3 Liquidity
BLNE has a Current Ratio of 1.05. This is a normal value and indicates that BLNE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.05, BLNE is in line with its industry, outperforming 50.00% of the companies in the same industry.
A Quick Ratio of 1.05 indicates that BLNE should not have too much problems paying its short term obligations.
BLNE has a Quick ratio (1.05) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.05 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 46.35% over the past year.
Looking at the last year, BLNE shows a very strong growth in Revenue. The Revenue has grown by 20.31%.
The Revenue for BLNE have been decreasing by -20.16% on average. This is quite bad
EPS 1Y (TTM)46.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.2%
Revenue 1Y (TTM)20.31%
Revenue growth 3Y-32.73%
Revenue growth 5Y-20.16%
Sales Q2Q%208.42%
3.2 Future
BLNE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.64% yearly.
Based on estimates for the next years, BLNE will show a very strong growth in Revenue. The Revenue will grow by 72.64% on average per year.
EPS Next Y-66.92%
EPS Next 2Y41.96%
EPS Next 3Y29.64%
EPS Next 5YN/A
Revenue Next Year-34.03%
Revenue Next 2Y50.76%
Revenue Next 3Y72.64%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for BLNE. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 43.01, which means the current valuation is very expensive for BLNE.
Based on the Price/Forward Earnings ratio, BLNE is valued a bit more expensive than the industry average as 73.47% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 23.70. BLNE is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 43.01 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as BLNE's earnings are expected to grow with 29.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.96%
EPS Next 3Y29.64%
5. Dividend
5.1 Amount
No dividends for BLNE!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
1.755
-0.08 (-4.1%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)
Earnings (Next)
Inst Owners9.31%
Inst Owner Change0%
Ins Owners18.67%
Ins Owner Change59.09%
Market Cap48.72M
Revenue(TTM)7.69M
Net Income(TTM)-28.92M
Analysts85.71
Price Target4.59 (161.54%)
Short Float %3.66%
Short Ratio1
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-9.99%
Min Revenue beat(2)-26.72%
Max Revenue beat(2)6.74%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-121.43%
EPS NQ rev (3m)-121.43%
EPS NY rev (1m)-2.81%
EPS NY rev (3m)-2.81%
Revenue NQ rev (1m)-7.95%
Revenue NQ rev (3m)-7.95%
Revenue NY rev (1m)-0.53%
Revenue NY rev (3m)-0.53%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 43.01 | ||
| P/S | 6.34 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.94 | ||
| P/tB | 3.59 | ||
| EV/EBITDA | N/A |
EPS(TTM)-23.9
EYN/A
EPS(NY)0.04
Fwd EY2.32%
FCF(TTM)-0.49
FCFYN/A
OCF(TTM)-0.47
OCFYN/A
SpS0.28
BVpS1.86
TBVpS0.49
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -45.78% | ||
| ROE | -55.9% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22% | ||
| FCFM | N/A |
ROA(3y)-45.89%
ROA(5y)-36.44%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.05%
GM growth 5Y5.13%
F-Score5
Asset Turnover0.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.05 | ||
| Altman-Z | -0.61 |
F-Score5
WACC7.43%
ROIC/WACCN/A
Cap/Depr(3y)62.29%
Cap/Depr(5y)46.27%
Cap/Sales(3y)7.25%
Cap/Sales(5y)5.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)46.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.2%
EPS Next Y-66.92%
EPS Next 2Y41.96%
EPS Next 3Y29.64%
EPS Next 5YN/A
Revenue 1Y (TTM)20.31%
Revenue growth 3Y-32.73%
Revenue growth 5Y-20.16%
Sales Q2Q%208.42%
Revenue Next Year-34.03%
Revenue Next 2Y50.76%
Revenue Next 3Y72.64%
Revenue Next 5YN/A
EBIT growth 1Y-278.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-208.53%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-364.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-379.02%
OCF growth 3YN/A
OCF growth 5YN/A
BEELINE HOLDINGS INC / BLNE FAQ
What is the fundamental rating for BLNE stock?
ChartMill assigns a fundamental rating of 2 / 10 to BLNE.
What is the valuation status for BLNE stock?
ChartMill assigns a valuation rating of 1 / 10 to BEELINE HOLDINGS INC (BLNE). This can be considered as Overvalued.
Can you provide the profitability details for BEELINE HOLDINGS INC?
BEELINE HOLDINGS INC (BLNE) has a profitability rating of 1 / 10.
What is the financial health of BEELINE HOLDINGS INC (BLNE) stock?
The financial health rating of BEELINE HOLDINGS INC (BLNE) is 3 / 10.
Can you provide the expected EPS growth for BLNE stock?
The Earnings per Share (EPS) of BEELINE HOLDINGS INC (BLNE) is expected to decline by -66.92% in the next year.